B - ORGANISMS
 
| 
Changed terms |   | 
Replaced-by |  
 
  | 
B01 - ANIMALS
 
B03 - BACTERIA
			 
B04 - VIRUSES
			 
B05 - FUNGI 
			
B06 - PLANTS 
			
			
 
  | 
			C - DISEASES
			 
			| 
			Changed terms |   | Replaced-by
			 |  
			 
			
  | 
C01 - BACTERIAL INFECTIONS AND MYCOSES 
C02 - VIRUS DISEASES
			 
			
C04 - NEOPLASMS 
C05 - MUSCULOSKELETAL DISEASES 
C06 - DIGESTIVE SYSTEM DISEASES 
C10 - NERVOUS SYSTEM DISEASES
 | Disease Models, Autoimmune, Nervous System | 
			 | Nervous System Autoimmune Disease, Experimental |  | Encephalomyelitis, Experimental Autoimmune | 
			 | Encephalomyelitis, Autoimmune, Experimental |  | Hematoma, Epidural | 
			 | Hematoma, Epidural, Cranial |  | Myasthenia Gravis, Experimental Autoimmune | 
			 | Myasthenia Gravis, Autoimmune, Experimental |  | Neuritis, Experimental Allergic | 
			 | Neuritis, Autoimmune, Experimental |   C14 - CARDIOVASCULAR DISEASES C17 - SKIN AND CONNECTIVE TISSUE DISEASES C18 - NUTRITIONAL AND METABOLIC DISEASES C19 - ENDOCRINE DISEASES C20 - IMMUNOLOGIC DISEASES C23 - PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS
 
 
  | 
D - CHEMICALS AND DRUGS
 | 
			Changed terms |   | Replaced-by |  
 
  | 
D02 - ORGANIC CHEMICALS D03 - HETEROCYCLIC COMPOUNDS
 
        
          | Bay-K-8644 | 
            | 
          3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 
         
        
          | BW-755C | 
            | 
          4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 
         
        
          | Ro 20-1724 | 
            | 
          4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone | 
         
        
          | Ro 4-1284 | 
            | 
          2H-Benzo(a)quinolizin-2-ol 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- | 
         
        
          | SC-19220 | 
            | 
          Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide | 
         
        
          | Sch-23390 | 
            | 
          (R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol | 
         
         
          | SK&F-38393 | 
		    | 
          2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 
         
       D04 - POLYCYCLIC HYDROCARBONS 
	  D08 - ENZYMES, COENZYMES, AND ENZYME INHIBITORS 
	  D09 - CARBOHYDRATES AND HYPOGLYCEMIC AGENTS 
	  
			D10 - LIPIDS AND ANTILIPEMIC AGENTS 
			D12 - AMINO ACIDS, PEPTIDES, AND PROTEINS 
			D24 - IMMUNOLOGIC AND BIOLOGICAL FACTORS 
			
 
  | 
E - ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT
 | 
			Changed terms 
			 |   | Replaced-by |  
 
  | 
			E01 - DIAGNOSIS 
			E05 - INVESTIGATIVE TECHNIQUES 
			E06 - DENTISTRY
 
 
  | 
F - PSYCHIATRY AND PSYCHOLOGY
 | 
			Changed terms
			 |   | Replaced-by |  
 
  | 
			F03 - MENTAL DISORDERS
 
 
  | 
G - BIOLOGICAL SCIENCES
 | 
			Changed terms |   | Replaced-by |  
 
  | 
G05 - GENETICS G06 - BIOCHEMICAL PHENOMENA, METABOLISM, AND NUTRITION G07 - PHYSIOLOGICAL PROCESSES G08 - REPRODUCTIVE AND URINARY PHYSIOLOGY G13 - GENETIC PHENOMENA
 
 
  | 
H - PHYSICAL SCIENCES
 | 
			Changed terms |   | 		
			Replaced-by |  
 
  | 
H01 - NATURAL SCIENCES
 
 
  | 
L - INFORMATION SCIENCE
 | 
			Changed terms |   | 
			Replaced-by |  
 
  | 
			L01 - INFORMATION SCIENCE 
			
 
  | 
			N - HEALTH CARE
 | 
			Changed terms |   | Replaced-by |  
 
  | 
			N02 - HEALTH CARE FACILITIES, MANPOWER, AND SERVICES
 
 
  |